OUR TEAM

Start up spirit, deep expertise

Seneque's scientific team consists of cellular longevity pioneers undertaking groundbreaking research at leading research institutes in California and Switzerland.

Our Scientific Advisory Board is led by Dr. Eric Verdin, a recognized NAD+ experts and President of the Buck Institute for Research on Aging.
DR. ERIC VERDIN
DR. ALESSIA GROZIO
GUILLAUME BERMOND
CHAIR, SENEQUE SCIENTIFIC
ADVISORY BOARD
CHIEF SCIENTIST, SENEQUE SCIENTIFIC ADVISORY BOARD
FOUNDER, SENEQUE
Dr. Verdin is the President of the Buck Institute for Research on Aging, a Professor of Medicine at the University of California, and the Chair of Seneque’s Scientific Advisory Board.
 Dr. Grozio is Seneque’s Chief Scientist
and a researcher at the Buck Institute for Research on Aging.

A recognized biologist with over 20 years experience in NAD+ metabolism and NMN, Dr. Grozio co-discovered a groundbreaking transporter that delivers NMN directly into cells.

Seneque was founded by successful French Entrepreneur Guillaume Bermond.

Passionate about biology, he gathered teams of geneticists, biochemists and statisticians across the USA and Europe to pursue his vision with the spirit and passion longevity research merits.
Show Biography
Dr. Verdin studies the relationship between aging and the immune system. His lab at the Buck Institute has demonstrated how changes in the relative abundance of key cellular metabolites such as NAD+ influence immune responses and the age-related state of chronic inflammation.

Dr. Verdin has been recognized for his research with a Glenn Award for Research in Biological Mechanisms of Aging, and a senior scholarship from the Ellison Medical Foundation.

He is an elected member of the American Association for the Advancement of Science,
the American Society for Clinical Investigation, and the Association of American Physicians.
Show Biography
As part of a team at Washington University School of Medicine, Dr. Grozio identified a previously unknown pathway used by NMN to restore NAD+ levels.

Thanks to this groundbreaking identification and characterization of a novel NMN transporter, Dr. Grozio significantly advanced understanding of NAD+ absorption and opened the door to more effective methods of NMN delivery.

Dr. Grozio earned her PhD in biochemistry at the University of Genoa in Italy and has been recognized for her research with a Tanaka Scholarship and Edward Schulak Scholarship.
 
As a recognized leader in the field of NAD+ metabolism and aging, she is a regular speaker at research conferences, seminars, and workshops around the world.

OUR TEAM

Start up spirit, deep expertise

Seneque's scientific team consists of 
cellular longevity pioneers undertaking
groundbreaking research
at leading research institutes
in California and Switzerland.

Our Scientific Advisory Board is led
by Dr. Eric Verdin, a recognized NAD+
experts and President of the
Buck Institute for Research on Aging.
DR.  ERIC VERDIN
CHAIR, SENEQUE SCIENTIFIC
ADVISORY BOARD
Dr. Verdin is the President of the Buck Institute for Research on Aging, a Professor of Medicine at the University of California, and the Chair of Seneque’s Scientific Advisory Board.
Show Biography
Dr. Verdin studies the relationship between aging and the immune system. His lab at the Buck Institute has demonstrated how changes in the relative abundance of key cellular metabolites such as NAD+ influence immune responses and the age-related state of chronic inflammation.

Dr. Verdin has been recognized for his research with a Glenn Award for Research in Biological Mechanisms of Aging, and a senior scholarship from the Ellison Medical Foundation.

He is an elected member of the American Association for the Advancement of Science,
the American Society for Clinical Investigation, and the Association of American Physicians.
DR. ALESSIA GROZIO
CHIEF SCIENTIST, SENEQUE SCIENTIFIC ADVISORY BOARD
 Dr. Grozio is Seneque’s Chief Scientist
and researcher at the Buck Institute for Research on Aging.

A recognized biologist with over 20 years experience in NAD+ metabolism and NMN, Dr. Grozio co-discovered a groundbreaking transporter that delivers NMN directly into cells.
Show Biography
As part of a team at Washington University School of Medicine, Dr. Grozio identified a previously unknown pathway used by NMN to restore NAD+ levels.

Thanks to this groundbreaking identification and characterization of a novel NMN transporter, Dr. Grozio significantly advanced understanding of NAD+ absorption and opened the door to more effective methods of NMN delivery.

Dr. Grozio earned her PhD in biochemistry at the University of Genoa in Italy and has been recognized for her research with a Tanaka Scholarship and Edward Schulak Scholarship.
 
As a recognized leader in the field of NAD+ metabolism and aging, she is a regular speaker at research conferences, seminars, and workshops around the world.

GUILLAUME BERMOND
FOUNDER, SENEQUE
Seneque was founded by successful French Entrepreneur Guillaume Bermond.

Passionate about biology, he gathered teams of geneticists, biochemists and statisticians across the USA and Europe to pursue his vision with the spirit and passion longevity research merits.